Entry Point Capital, LLC Celcuity Inc. Transaction History
Entry Point Capital, LLC
- $221 Million
- Q4 2024
A detailed history of Entry Point Capital, LLC transactions in Celcuity Inc. stock. As of the latest transaction made, Entry Point Capital, LLC holds 20,847 shares of CELC stock, worth $215,557. This represents 0.12% of its overall portfolio holdings.
Number of Shares
20,847
Previous 20,875
0.13%
Holding current value
$215,557
Previous $311,000
12.54%
% of portfolio
0.12%
Previous 0.18%
Shares
2 transactions
Others Institutions Holding CELC
# of Institutions
104Shares Held
30MCall Options Held
17.5KPut Options Held
100-
Bvf Inc San Francisco, CA3.47MShares$35.8 Million1.7% of portfolio
-
Baker Bros. Advisors LP New York, NY2.68MShares$27.7 Million0.39% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.57MShares$26.5 Million2.34% of portfolio
-
Perceptive Advisors LLC New York, NY2.36MShares$24.4 Million1.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.65MShares$17.1 Million0.0% of portfolio
About Celcuity Inc.
- Ticker CELC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 14,941,300
- Market Cap $154M
- Description
- Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therap...